Clinical Study Protocol Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011 in Infants Aged Between 6-12 months Old.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2012
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- Sponsors Adimmune Corporation
- 19 Jan 2012 Actual start date (1 Nov 2010) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual end date (1 Sep 2011) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.